{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:56:03Z","timestamp":1790034963913,"version":"4.0.1"},"reference-count":120,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,5]]},"abstract":"<jats:p>The International Consensus Classification (ICC) of myeloid and lymphoid neoplasms follows the precedent set in the Revised European-American lymphoma classification for modern lymphoma classifications by defining specific diseases on the basis of all the available morphologic, immunophenotypic, genetic, and clinical findings. Primary cutaneous lymphomas exhibit a broad range of clinical behavior ranging from lesions which spontaneously regress to those which run an aggressive, often fatal course. Accurate separation of entities is therefore essential for prognostication and to ensure appropriate treatment is administered. However, despite marked differences in clinical course, many subtypes of primary cutaneous lymphoma exhibit remarkably similar, often overlapping, and sometimes indistinguishable pathologic features. While molecular analysis has furthered our understanding of some of these disease entities, it does not yet facilitate robust distinction. Thus, clinical correlation retains a central role in both the diagnosis and classification of primary cutaneous lymphoma. This review aims to draw attention to problem areas in differential diagnosis and hopefully offer some practical suggestions for resolving difficult cases. It will also highlight recent advances in the field and discuss how they reinforce the current classification system and how they might impact of future classifications and treatment strategies.<\/jats:p>","DOI":"10.1097\/pap.0000000000000487","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T11:00:40Z","timestamp":1741690840000},"page":"239-255","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Updated Classification of Cutaneous Lymphoma"],"prefix":"10.1097","volume":"32","author":[{"given":"John R.","family":"Goodlad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"R2-20250414","first-page":"354","article-title":"EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer","volume":"90","author":"Willemze","year":"1997","journal-title":"Blood"},{"key":"R3-20250414","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"R4-20250414","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.0736-8046.2004.21500.x","article-title":"The spectrum of cutaneous lymphomas in patients less than 20 years of age","volume":"21","author":"Fink-Puches","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"R5-20250414","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/cup.14111","article-title":"IRTA1 positivity helps identify a MALT-lymphoma-like subset of primary cutaneous marginal zone lymphomas, largely but not exclusively defined by IgM expression","volume":"49","author":"Carlsen","year":"2022","journal-title":"J Cutan Pathol"},{"key":"R6-20250414","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1182\/blood-2008-01-132415","article-title":"The majority of cutaneous marginal zone B-cell lymphomas expresses class-switched immunoglobulins and develops in a T-helper type 2 inflammatory environment","volume":"112","author":"van Maldegem","year":"2008","journal-title":"Blood"},{"key":"R7-20250414","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1097\/PAS.0b013e3181f72835","article-title":"Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets","volume":"34","author":"Edinger","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R8-20250414","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/modpathol.2013.106","article-title":"Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression","volume":"26","author":"Brenner","year":"2013","journal-title":"Mod Pathol"},{"key":"R9-20250414","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/PAS.0000000000001363","article-title":"Class-switched primary cutaneous marginal zone lymphomas are frequently IgG4-positive and have features distinct from IgM-positive cases","volume":"43","author":"Carlsen","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R10-20250414","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/path.1711","article-title":"FISH analysis of MALT lymphoma-specific translocations and aneuploidy in primary cutaneous marginal zone lymphoma","volume":"205","author":"Schreuder","year":"2005","journal-title":"J Pathol"},{"key":"R11-20250414","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","article-title":"Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites","volume":"18","author":"Streubel","year":"2004","journal-title":"Leukemia"},{"key":"R12-20250414","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jid.2018.02.015","article-title":"Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma","volume":"138","author":"Maurus","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R13-20250414","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1200\/JCO.2006.09.6396","article-title":"Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers","volume":"25","author":"Senff","year":"2007","journal-title":"J Clin Oncol"},{"key":"R14-20250414","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1182\/blood-2008-04-152850","article-title":"European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas","volume":"112","author":"Senff","year":"2008","journal-title":"Blood"},{"issue":"suppl 6","key":"R15-20250414","doi-asserted-by":"crossref","first-page":"vi149","DOI":"10.1093\/annonc\/mdt242","article-title":"Primary cutaneous lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Willemze","year":"2013","journal-title":"Ann Oncol"},{"key":"R16-20250414","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"R17-20250414","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/PAS.0000000000000388","article-title":"Cutaneous spindle-cell B-cell lymphomas: most are neoplasms of follicular center cell origin","volume":"39","author":"Charli-Joseph","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R18-20250414","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2133.2001.04323.x","article-title":"Spindle-cell B-cell lymphoma presenting in the skin","volume":"145","author":"Goodlad","year":"2001","journal-title":"Br J Dermatol"},{"key":"R19-20250414","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00000478-200206000-00006","article-title":"Primary cutaneous follicular lymphoma: a clinicopathologic and molecular study of 16 cases in support of a distinct entity","volume":"26","author":"Goodlad","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R20-20250414","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/PAS.0000000000000567","article-title":"Primary cutaneous follicle center lymphomas expressing BCL2 protein frequently harbor BCL2 gene break and may present 1p36 deletion: a study of 20 cases","volume":"40","author":"Szablewski","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R21-20250414","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.humpath.2020.09.014","article-title":"The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma","volume":"106","author":"Barasch","year":"2020","journal-title":"Hum Pathol"},{"key":"R22-20250414","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/his.13279","article-title":"Diagnostic value of STMN1, LMO2, HGAL, AID expression and 1p36 chromosomal abnormalities in primary cutaneous B cell lymphomas","volume":"71","author":"Verdanet","year":"2017","journal-title":"Histopathology"},{"key":"R23-20250414","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jaad.2014.03.027","article-title":"Primary cutaneous follicle center lymphoma with diffuse CD30 expression: a report of 4 cases of a rare variant","volume":"71","author":"Kempf","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"R24-20250414","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00000478-200206000-00006","article-title":"Primary cutaneous follicular lymphoma\u2013a clinicopathologic and molecular study of 16 cases in support of a distinct entity","volume":"26","author":"Goodlad","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R25-20250414","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/00000478-200312000-00006","article-title":"Primary cutaneous diffuse large B-cell lymphoma: prognostic significance of clinicopathological subtypes","volume":"27","author":"Goodlad","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R26-20250414","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/bloodadvances.2020002469","article-title":"Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features","volume":"5","author":"Zhou","year":"2021","journal-title":"Blood Adv"},{"key":"R27-20250414","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00428-018-2384-3","article-title":"Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein","volume":"473","author":"G\u00e1ng\u00f3","year":"2018","journal-title":"Virchows Arch"},{"key":"R28-20250414","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"key":"R29-20250414","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3324\/haematol.2012.073916","article-title":"Recurrent loss of heterozygosity in 1p36 associated with TNFRSF14 mutations in IRF4 translocation negative pediatric follicular lymphomas","volume":"98","author":"Martin-Guerrero","year":"2013","journal-title":"Haematologica"},{"key":"R30-20250414","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.2021012057","article-title":"Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC","volume":"140","author":"Olsen","year":"2022","journal-title":"Blood"},{"key":"R31-20250414","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1182\/blood-2005-03-1175","article-title":"Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients","volume":"106","author":"Kodama","year":"2005","journal-title":"Blood"},{"key":"R32-20250414","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1200\/JCO.2005.03.6285","article-title":"Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas","volume":"24","author":"Zinzani","year":"2006","journal-title":"J Clin Oncol"},{"key":"R33-20250414","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1001\/archderm.143.9.1144","article-title":"Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases","volume":"143","author":"Grange","year":"2007","journal-title":"Arch Dermatol"},{"key":"R34-20250414","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00428-021-03265-5","article-title":"Cell-of-origin classification using the Hans and lymph2Cx algorithms in primary cutaneous large B-cell lymphomas","volume":"480","author":"Schrader","year":"2022","journal-title":"Virchows Arch"},{"key":"R35-20250414","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/PAS.0b013e3181e5060a","article-title":"IgM expression on paraffin sections distinguishes primary cutaneous large B-cell lymphoma, leg type from primary cutaneous follicle center lymphoma","volume":"34","author":"Koens","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R36-20250414","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1182\/blood-2004-04-1594","article-title":"Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling","volume":"105","author":"Hoefnagel","year":"2005","journal-title":"Blood"},{"key":"R37-20250414","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/cup.13955","article-title":"TdT-positive primary cutaneous diffuse large B-cell lymphoma, leg type phenotypically mimicking B-lymphoblastic lymphoma","volume":"48","author":"Endo","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R38-20250414","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/cup.13795","article-title":"A case of primary cutaneous B-cell lymphoma with immature features in an old man. Diffuse large B-cell lymphoma with immature features or B-cell lymphoblastic lymphoma?","volume":"48","author":"Ronchi","year":"2021","journal-title":"J Cutan Pathol"},{"key":"R39-20250414","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1097\/PAS.0000000000001132","article-title":"High incidence and clinical significance of MYC rearrangements in primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"42","author":"Schrader","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R40-20250414","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/j.0022-202X.2003.12635.x","article-title":"Chromosomal aberration patterns differ in subtypes of primary cutaneous B cell lymphomas","volume":"122","author":"Hallermann","year":"2004","journal-title":"J Invest Dermatol"},{"key":"R41-20250414","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/modpathol.2013.156","article-title":"Multiple genetic alterations in primary cutaneous large B-cell lymphoma, leg type support a common lymphomagenesis with activated B-cell-like diffuse large B-cell lymphoma","volume":"27","author":"Pham-Ledard","year":"2014","journal-title":"Mod Pathol"},{"key":"R42-20250414","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1182\/blood-2017-12-822817","article-title":"High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma","volume":"131","author":"Schrader","year":"2018","journal-title":"Blood"},{"key":"R43-20250414","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/j.jid.2017.04.010","article-title":"Identification of somatic mutations in primary cutaneous diffuse large B-cell lymphoma, leg type by massive parallel sequencing","volume":"137","author":"Mareschal","year":"2017","journal-title":"J Invest Dermatol"},{"key":"R44-20250414","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.ccell.2020.03.015","article-title":"A probabilistic classification tool for genetic subtypes of diffuse large B cell lymphoma with therapeutic implications","volume":"37","author":"Wright","year":"2020","journal-title":"Cancer Cell"},{"key":"R45-20250414","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jamadermatol.2014.821","article-title":"High frequency and clinical prognostic value of MYD88 L265P mutation in primary cutaneous diffuse large B-cell lymphoma, leg-type","volume":"150","author":"Pham-Ledard","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R46-20250414","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jamadermatol.2013.7452","article-title":"Improvement of survival in patients with primary cutaneous diffuse large B-cell lymphoma, leg type, in France","volume":"150","author":"Grange","year":"2014","journal-title":"JAMA Dermatol"},{"key":"R47-20250414","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/bjh.17886","article-title":"Rituximab, lenalidomide, and ibrutinib in relapsed\/refractory primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"196","author":"Moore","year":"2022","journal-title":"Br J Haematol"},{"key":"R48-20250414","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/jid.2012.102","article-title":"MYD88 somatic mutation is a genetic feature of primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"132","author":"Pham-Ledard","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R49-20250414","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/his.13832","article-title":"Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 cases","volume":"74","author":"Menguy","year":"2019","journal-title":"Histopathology"},{"key":"R50-20250414","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00428-022-03421-5","article-title":"Recent advances in cutaneous lymphoma-implications for current and future classifications","volume":"482","author":"Goodlad","year":"2023","journal-title":"Virchows Arch"},{"key":"R51-20250414","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07526.x","article-title":"Mycosis fungoides: a dermatological masquerader","volume":"156","author":"Nashan","year":"2007","journal-title":"Br J Dermatol"},{"key":"R52-20250414","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1097\/01.pas.0000153121.57515.c6","article-title":"Histopathologic features of early (patch) lesions of mycosis fungoides: a morphologic study on 745 biopsy specimens from 427 patients","volume":"29","author":"Massone","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R55-20250414","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00000372-200202000-00002","article-title":"Low CD7 expression in benign and malignant cutaneous lymphocytic infiltrates: experience with an antibody reactive with paraffin-embedded tissue","volume":"24","author":"Murphy","year":"2002","journal-title":"Am J Dermatopathol"},{"key":"R56-20250414","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1600-0560.2009.01323.x","article-title":"CD4\/CD8 double negative pagetoid reticulosis: a case report and literature review","volume":"37","author":"Mourtzinos","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R57-20250414","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2133.2005.06649.x","article-title":"T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction\/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides\/S\u00e9zary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings","volume":"153","author":"Ponti","year":"2005","journal-title":"Br J Dermatol"},{"key":"R58-20250414","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12308-012-0145-9","article-title":"Clonality testing of cutaneous lymphoid infiltrates: practicalities, pitfalls and potential uses","volume":"5","author":"Sproul","year":"2012","journal-title":"J Haematopathol"},{"key":"R59-20250414","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jaad.2007.06.004","article-title":"T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides","volume":"57","author":"Thurber","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R60-20250414","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/gcc.22679","article-title":"Genomic analysis reveals recurrent deletion of JAK-STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides","volume":"57","author":"Bastidas Torres","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"R61-20250414","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ng.3356","article-title":"Genomic landscape of cutaneous T cell lymphoma","volume":"47","author":"Choi","year":"2015","journal-title":"Nat Genet"},{"key":"R62-20250414","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1182\/blood.2019004256","article-title":"Genetic and epigenetic insights into cutaneous T-cell lymphoma","volume":"139","author":"Tensen","year":"2022","journal-title":"Blood"},{"key":"R63-20250414","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"R64-20250414","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"R65-20250414","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamadermatol.2016.1597","article-title":"Clinical staging and prognostic factors in folliculotropic mycosis fungoides","volume":"152","author":"van Santen","year":"2016","journal-title":"JAMA Dermatol"},{"key":"R66-20250414","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/cup.12353","article-title":"A review of the solitary cutaneous T-cell lymphomas","volume":"41","author":"Ally","year":"2014","journal-title":"J Cutan Pathol"},{"key":"R67-20250414","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2340\/00015555-1971","article-title":"Delay in the histopathologic diagnosis of mycosis fungoides","volume":"95","author":"Skov","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"R68-20250414","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0190-9622(93)70140-O","article-title":"Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment","volume":"28","author":"Willemze","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"R69-20250414","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas","volume":"37","author":"Kempf","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"R70-20250414","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"R71-20250414","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archderm.140.4.441","article-title":"Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C","volume":"140","author":"El Shabrawi-Caelen","year":"2004","journal-title":"Arch Dermatol"},{"key":"R72-20250414","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":"A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases","volume":"34","author":"Saggini","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R73-20250414","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1097\/PAS.0b013e318282d01e","article-title":"Chromosomal rearrangements of 6p25.3 define a new subtype of lymphomatoid papulosis","volume":"37","author":"Karai","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"suppl 1","key":"R74-20250414","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0303-6987.2006.00548.x","article-title":"CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators","volume":"33","author":"Kempf","year":"2006","journal-title":"J Cutan Pathol"},{"key":"R75-20250414","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jaad.2009.05.014","article-title":"Clinical, histopathologic, and immunophenotypic features of lymphomatoid papulosis with CD8 predominance in 14 pediatric patients","volume":"61","author":"de Souza","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"R76-20250414","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.humpath.2014.12.008","article-title":"Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin","volume":"46","author":"de la Garza Bravo","year":"2015","journal-title":"Hum Pathol"},{"key":"R77-20250414","doi-asserted-by":"crossref","first-page":"100068","DOI":"10.1016\/j.xjidi.2021.100068","article-title":"Genomic analysis of cutaneous CD30-positive lymphoproliferative disorders","volume":"2","author":"Abdulla","year":"2022","journal-title":"JID Innov"},{"key":"R78-20250414","doi-asserted-by":"crossref","first-page":"100034","DOI":"10.1016\/j.xjidi.2021.100034","article-title":"Oncogenic mutations and gene fusions in CD30-positive lymphoproliferations and clonally related mycosis fungoides occurring in the same patients","volume":"1","author":"Wobser","year":"2021","journal-title":"JID Innov"},{"key":"R79-20250414","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1097\/PAS.0000000000000474","article-title":"Intralymphatic spread is a common finding in cutaneous CD30+ lymphoproliferative disorders","volume":"39","author":"Ferrara","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R80-20250414","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-0560.2007.00778.x","article-title":"The morphologic spectrum of primary cutaneous anaplastic large T-cell lymphoma: a histopathologic study on 66 biopsy specimens from 47 patients with report of rare variants","volume":"35","author":"Massone","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R81-20250414","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/his.12529","article-title":"Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features","volume":"66","author":"Onaindia","year":"2015","journal-title":"Histopathology"},{"key":"R82-20250414","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1046\/j.1365-2133.2003.05248.x","article-title":"Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature","volume":"148","author":"Burg","year":"2003","journal-title":"Br J Dermatol"},{"key":"R83-20250414","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00000478-199504000-00002","article-title":"Neutrophil-rich, Ki-1-positive anaplastic large-cell malignant lymphoma","volume":"19","author":"Mann","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R84-20250414","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"R85-20250414","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.2012.065664","article-title":"ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study","volume":"98","author":"Oschlies","year":"2013","journal-title":"Haematologica"},{"key":"R86-20250414","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/bjh.14404","article-title":"Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience","volume":"176","author":"Hapgood","year":"2017","journal-title":"Br J Haematol"},{"key":"R87-20250414","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.jaad.2010.07.028","article-title":"Reappraisal of the provisional entity primary cutaneous CD4+ small\/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature","volume":"65","author":"Baum","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"R88-20250414","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"R89-20250414","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1200\/JCO.2008.16.1307","article-title":"Primary cutaneous small\/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome","volume":"26","author":"Garcia-Herrera","year":"2008","journal-title":"J Clin Oncol"},{"key":"R90-20250414","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol"},{"key":"R91-20250414","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000212118","article-title":"Solitary small- to medium-sized pleomorphic T-cell nodules of undetermined significance: clinical, histopathological, immunohistochemical and molecular analysis of 26 cases","volume":"219","author":"Leinweber","year":"2009","journal-title":"Dermatology"},{"key":"R92-20250414","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":"Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers","volume":"33","author":"Rodr\u00edguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R93-20250414","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/PAS.0000000000001984","article-title":"Overlapping features of primary cutaneous marginal zone lymphoproliferative disorder and primary cutaneous CD4 + small\/medium T-cell lymphoproliferative disorder : a diagnostic challenge examined by genomic analysis","volume":"47","author":"Obiorah","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"R94-20250414","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/PAS.0000000000001470","article-title":"Primary cutaneous CD4+ small\/medium T-cell lymphoproliferative disorders: a clinical, pathologic, and molecular study of 60 cases presenting with a single lesion: a multicenter study of the French Cutaneous Lymphoma Study Group","volume":"44","author":"Beltzung","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R95-20250414","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/bjd.21791","article-title":"Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study","volume":"187","author":"Wang","year":"2022","journal-title":"Br J Dermatol"},{"key":"R96-20250414","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1038\/s41598-023-33031-3","article-title":"Deciphering the spectrum of cutaneous lymphomas expressing TFH markers","volume":"13","author":"Donzel","year":"2023","journal-title":"Sci Rep"},{"key":"R97-20250414","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/PAS.0b013e318068b527","article-title":"Indolent CD8-positive lymphoid proliferation of the ear: a distinct primary cutaneous T-cell lymphoma?","volume":"31","author":"Petrella","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R98-20250414","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1600-0560.2009.01448.x","article-title":"Indolent CD8-positive lymphoid proliferation on the face: part of the spectrum of primary cutaneous small-\/medium-sized pleomorphic T-cell lymphoma or a distinct entity?","volume":"37","author":"Suchak","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R99-20250414","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cup.12045","article-title":"Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features","volume":"40","author":"Greenblatt","year":"2013","journal-title":"J Cutan Pathol"},{"key":"R101-20250414","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/bjd.13628","article-title":"CD68 expression is a discriminative feature of indolent cutaneous CD8-positive lymphoid proliferation and distinguishes this lymphoma subtype from other CD8-positive cutaneous lymphomas","volume":"172","author":"Wobser","year":"2015","journal-title":"Br J Dermatol"},{"key":"R102-20250414","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0560.2009.01278.x","article-title":"Indolent CD8+ lymphoid proliferation of the ear: a phenotypic variant of the small-medium pleomorphic cutaneous T-cell lymphoma?","volume":"37","author":"Beltraminelli","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R103-20250414","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/bjd.20973","article-title":"Clinical, histopathological and prognostic features of primary cutaneous acral CD8(+) T-cell lymphoma and other dermal CD8(+) cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop","volume":"186","author":"Kempf","year":"2022","journal-title":"Br J Dermatol"},{"key":"R104-20250414","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/his.12371","article-title":"Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop","volume":"67","author":"Robson","year":"2015","journal-title":"Histopathology"},{"key":"R105-20250414","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol"},{"key":"R106-20250414","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0190-9622(90)70074-R","article-title":"Cutaneous T cell lymphoma with suppressor\/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes","volume":"22","author":"Agnarsson","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"R107-20250414","doi-asserted-by":"crossref","first-page":"702","DOI":"10.3324\/haematol.2020.274506","article-title":"Deregulation of JAK2 signaling underlies primary cutaneous CD8(+) aggressive epidermotropic cytotoxic T-cell lymphoma","volume":"107","author":"Bastidas Torres","year":"2022","journal-title":"Haematologica"},{"key":"R108-20250414","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"key":"R109-20250414","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/bjd.13440","article-title":"Subcutaneous panniculitis-like T-cell lymphoma in children: a detailed clinicopathological description of 11 multifocal cases with a high frequency of haemophagocytic syndrome","volume":"172","author":"Oschlies","year":"2015","journal-title":"Br J Dermatol"},{"key":"R110-20250414","first-page":"1058","article-title":"HAVCR2 mutations are associated with severe hemophagocytic syndrome in subcutaneous panniculitis-like T-cell lymphoma","volume":"135","author":"Sonigo","year":"2020","journal-title":"Blood"},{"key":"R111-20250414","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jaad.2018.05.1243","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: clinical features, therapeutic approach, and outcome in a case series of 16 patients","volume":"79","author":"L\u00f3pez-Lerma","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"R112-20250414","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/bjh.14611","article-title":"Recurrent mutations in epigenetic modifiers and the PI3K\/AKT\/mTOR pathway in subcutaneous panniculitis-like T-cell lymphoma","volume":"181","author":"Li","year":"2018","journal-title":"Br J Haematol"},{"key":"R113-20250414","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1182\/bloodadvances.2018028340","article-title":"Frequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma","volume":"3","author":"Polprasert","year":"2019","journal-title":"Blood Adv"},{"key":"R114-20250414","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1182\/bloodadvances.2021004562","article-title":"Genetic profiles of subcutaneous panniculitis-like T-cell lymphoma and clinicopathological impact of HAVCR2 mutations","volume":"5","author":"Koh","year":"2021","journal-title":"Blood Adv"},{"key":"R115-20250414","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41588-018-0251-4","article-title":"Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndrome","volume":"50","author":"Gayden","year":"2018","journal-title":"Nat Genet"},{"key":"R116-20250414","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/PAS.0000000000000307","article-title":"Lobular panniculitic infiltrates with overlapping histopathologic features of lupus panniculitis (lupus profundus) and subcutaneous T-cell lymphoma: a conceptual and practical dilemma","volume":"39","author":"Bosisio","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R117-20250414","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/PAS.0000000000000596","article-title":"Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis","volume":"40","author":"LeBlanc","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R118-20250414","doi-asserted-by":"crossref","first-page":"e255592","DOI":"10.1136\/bcr-2023-255592","article-title":"Subcutaneous panniculitis-like T-cell lymphoma and lupus erythematosus profundus: a diagnostic dilemma","volume":"17","author":"Lee","year":"2024","journal-title":"BMJ Case Rep"},{"key":"R119-20250414","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"key":"R120-20250414","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous gammadelta T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R121-20250414","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/archderm.136.8.1024","article-title":"gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"key":"R122-20250414","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1053\/j.semdp.2016.11.009","article-title":"Cutaneous lymphomas with a panniculitic presentation","volume":"34","author":"Willemze","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"R123-20250414","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/s41467-020-15572-7","article-title":"Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas","volume":"11","author":"Daniels","year":"2020","journal-title":"Nat Commun"},{"key":"R124-20250414","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jaad.2020.10.012","article-title":"Diagnosis of gamma\/delta mycosis fungoides requires longitudinal clinical observation","volume":"85","author":"Ferrier","year":"2021","journal-title":"J Am Acad Dermatol"}],"container-title":["Advances in Anatomic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000487","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T07:00:28Z","timestamp":1744614028000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAP.0000000000000487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":120,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pap.0000000000000487","relation":{},"ISSN":["1072-4109","1533-4031"],"issn-type":[{"value":"1072-4109","type":"print"},{"value":"1533-4031","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]}}}